Oxolamine citrate salt
CAS: 1949-20-8
Rif. 3D-BAA94920
2g | 136,00 € | ||
5g | 172,00 € | ||
10g | 248,00 € | ||
25g | 363,00 € | ||
50g | 518,00 € |
Informazioni sul prodotto
- 1,2,4-Oxadiazole, 5-[2-(diethylamino)ethyl]-3-phenyl-, citrate (1:1)
- 1,2,4-Oxadiazole-5-ethanamine, N,N-diethyl-3-phenyl-, 2-hydroxy-1,2,3-propanetricarboxylate (1:1)
- 3-Phenyl-5-(diethylaminoethyl)-1,2,4-oxadiazole citrate
- 5-(Diethylaminoethyl)-3-phenyl-1,2,4-oxadiazole citrate
- 5-[2-(Diethylamino)Ethyl]-3-Phenyl-1,2,4-Oxadiazole Citrate Salt
- Af 438
- Bredon
- Broncatar
- Flogobron
- N,N-diethyl-2-(3-phenyl-1,2,4-oxadiazol-5-yl)ethanaminium 3,4-dicarboxy-3-hydroxybutanoate
- Vedi altri sinonimi
- NSC 100298
- Oxarmin
- Oxolamine Dihydrogen Citrate
- Perebron
- Prilon
- Skf 9976
Oxolamine citrate salt is a pharmaceutical drug used for the treatment of scleroderma. It acts as an iron chelator and inhibits the production of the cytotoxic agent, podophyllotoxin, by inhibiting its conversion to epipodophyllotoxin. Oxolamine citrate salt has been shown to have a beneficial effect on Alzheimer's disease and may have therapeutic potential in other neurological diseases such as Parkinson's disease. The compound has been shown to inhibit acetonitrile-induced hyperactivity in mice. Oxolamine citrate salt has also been found to be effective against Pseudomonas aeruginosa and Staphylococcus aureus isolates that are resistant to oxacillin, ginkgetin, or pseudoephedrine. This drug can be analyzed using liquid chromatography with an acetonitrile gradient and a hypersil C18 column.
Proprietà chimiche
Richiesta tecnica su: 3D-BAA94920 Oxolamine citrate salt
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.